CONTACT

DermatoPoietin® - Platform Technology | More about DermatoPoietin® Cosmetics

9 slider effects 20 built-in patterns Interleukin-1 alpha in Paracrine Interactions Interleukin-1 alpha regulates activity of papilla cells Interleukin-1 alpha and Aging Interleukin-1 alpha and collagen production / breakdown rh-Interleukin-1 alpha does not penetrate human epidermis DermatoPoietin® mode of action Introduction to DermatoPoietin® Introduction to DermatoPoietin® Potential Applications of Interleukin-1 alpha DermatoPoietin® Platform Technology Clinical Trial #1 Clinical Trial #1. Ultrasonograms 20MHz Clinical Trial #1. Results Clinical Trial #2 Clinical Trial #2. Ultrasonograms 20MHz Clinical Trial #2. Ultrasonograms 20MHz Clinical Trial #2. Results Clinical Trial #3. Study Schedule Clinical Trial #3. Results Clinical Trial #3. Average Change of Hair Shedding for 3 months Clinical Trial #4. Study Schedule Clinical Trial #4. Results Proprietary Position Conclusions Clinical Trial #3. Average Change of Hair Shedding for 3 months Clinical Trial #4. Study Schedule Clinical Trial #4. Results Proprietary Position Conclusions
X

Send Email

X

Search This Site

X

Login